Clinical Trial Update: Blinatumomab in Combination With AMG 404 for the Treatment of Adults With Relapsed or Refractory B Cell Precursor ALL [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating blinatumomab with AMG 404 in adults with relapsed or refractory B cell precursor acute lymphoblastic leukemia has completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• AMG 404
• Blinatumomab (blinatumomab)

Snippet

Sponsor: Amgen | Conditions: Acute Lymphoblastic Leukemia | Phase 1 | Status: COMPLETED | Results posted: 2024-04-08